Cosmetic skin lightening: Contextualizing biomedical and ethical issues.

Autor: Parente JBM; University of Pennsylvania, Philadelphia, Pennsylvania, USA., Silva GS; Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA., Gotschall JW; Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA., Ferreira AL; Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA., Grant-Kels JM; Department of Dermatology, University of Connecticut Health Center, Farmington, Connecticut, USA; Department of Dermatology, University of Florida, Gainesville, Florida, USA. Electronic address: grant@uchc.edu.
Jazyk: angličtina
Zdroj: Clinics in dermatology [Clin Dermatol] 2024 Sep-Oct; Vol. 42 (5), pp. 513-514. Date of Electronic Publication: 2024 Apr 13.
DOI: 10.1016/j.clindermatol.2024.04.001
Abstrakt: The skin-lightening (SL) industry has a global reach and is projected to continue to grow over the coming decade. Although SL treatments may be safely prescribed for the treatment of some dermatologic conditions, many over-the-counter SL products contain ingredients that can cause harm to the skin and other organ systems. Given a lack of transparent information to patients and the historical colorist foundation that contextualizes a component of the cosmetic SL industry, dermatologists need to navigate biomedical and ethical concerns when explaining SL products to patients. This commentary briefly outlines the medical ethical issues surrounding this topic and describes avenues by which dermatologists may provide informed patient care that best supports beneficence, justice, autonomy, and nonmaleficence.
Competing Interests: Declaration of competing interest The authors declare no conflicts of interest.
(Copyright © 2024 Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: